A Cannabinoid Agonist Interferes With The Progression Of A Chronic Model Of Multiple Sclerosis By Downregulating Adhesion Molecules

Multiple Sclerosis (MS)

Key Findings

Inhibition of brain adhesion molecules may produce therapeutic effects in MS.

Information and Links


Link: A Cannabinoid Agonist Interferes With The Progression Of A Chronic Model Of Multiple Sclerosis By Downregulating Adhesion Molecules

Year: 2009

DOI: 10.1016/j.mcn.2008.10.015


Ratings

(How Ratings Work)

Multiple Sclerosis (MS) — 2


Possible to probable range of efficacy of cannabis for treatment of Multiple Sclerosis (MS) according to the results found in this study.

Drugs Used

WIN55,212-2